Rheumatoid arthritis.

GUIDELINE TITLE
Rheumatoid arthritis. The management of rheumatoid arthritis in adults.

BIBLIOGRAPHIC SOURCE(S)
National Collaborating Centre for Chronic Conditions. Rheumatoid arthritis: the management of rheumatoid arthritis in adults. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Feb. 35 p. (NICE clinical guideline; no. 79).

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: National Institute for Clinical Excellence (NICE). Anakinra for rheumatoid arthritis. London (UK): National Institute for Clinical Excellence (NICE); 2003 Nov. 19 p. (Technology appraisal; no. 72).

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

September 11, 2008 - Rituxan (Rituximab): Genentech informed healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML) leading to death in a patient with rheumatoid arthritis who received Rituxan in a long-term safety extension clinical study.

abrir aquí para acceder al documento AHRQ NGC completo:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=14310&nbr=&string=